The landscape of COVID-19 vaccinations for children is shifting in the US. How will this affect the upcoming virus season?

Coronavirus infections are climbing again, marking another summer wave as children go back to school. But this uptick arrives ...

The potential move to rescind authorization of Pfizer's vaccine could leave some kids in the U.S. with no available shots ...

The Food and Drug Administration could pull Pfizer's coronavirus vaccine emergency authorization for children under age 5.

Parents won't be able to vaccinate healthy children 6 months to 5 years old if the FDA pulls Pfizer's COVID-19 vaccine authorization.

Parents in the United States who want to vaccinate their young children against Covid-19 this fall may face a growing set of ...

“We’ve stepped back into the world that we lived in before the [CDC’s vaccine advisory committee] was created,” said Dr.

Under Robert F. Kennedy Jr., federal officials may withdraw an endorsement for the vaccine in younger children.

COVID-19 activity is rising in much of the country. Data shows overall respiratory virus spread is very low in the U.S.

Pfizer also said it is working to improve its existing vaccine formulation, developed jointly with Germany's BioNTech, based on the vaccine's reaction to new COVID-19 variants that arise.

Pfizer’s clinical trials in children 5 to 11 did not measure the vaccine’s effectiveness against COVID-19. Effectiveness was “never the intended primary endpoint,” Anderson said.

London — U.S. drugmaker Pfizer said Monday that human trials suggest its coronavirus vaccine is 90% effective at preventing COVID-19 infections in people not known to have had the virus already.